Retrieve available abstracts of 29 articles: HTML format
Single Articles
March 2025
LEE HJ, Park SW, Lee JH, Chang SY, et al Differential cellular origins of the extracellular matrix of tumor and normal
tissues according to colorectal cancer subtypes.
Br J Cancer. 2025 Mar 3. doi: 10.1038/s41416-025-02964. PubMedAbstract available
December 2024
LEUNG EYL, Robbins HL, Zaman S, Lal N, et al The potential clinical utility of Whole Genome Sequencing for patients with
cancer: evaluation of a regional implementation of the 100,000 Genomes Project.
Br J Cancer. 2024;131:1805-1813. PubMedAbstract available
November 2024
TAN R, Wen M, Yang W, Zhan D, et al Integrated proteomics and scRNA-seq analyses of ovarian cancer reveal molecular
subtype-associated cell landscapes and immunotherapy targets.
Br J Cancer. 2024 Nov 15. doi: 10.1038/s41416-024-02894. PubMedAbstract available
KAUFMANN M, Vaysse PM, Savage A, Kooreman LFS, et al Testing of rapid evaporative mass spectrometry for histological tissue
classification and molecular diagnostics in a multi-site study.
Br J Cancer. 2024;131:1298-1308. PubMedAbstract available
TORR B, Jones C, Kavanaugh G, Hamill M, et al BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK
breast oncology setting: a randomised, non-inferiority trial.
Br J Cancer. 2024;131:1506-1515. PubMedAbstract available
October 2024
SHEN M, Garcia-Marques F, Muruganantham A, Liu S, et al Identification of a 5-gene signature panel for the prediction of prostate cancer
progression.
Br J Cancer. 2024 Oct 14. doi: 10.1038/s41416-024-02854. PubMedAbstract available
August 2024
NAGELBERG AL, Sihota TS, Chuang YC, Shi R, et al Integrative genomics identifies SHPRH as a tumor suppressor gene in lung
adenocarcinoma that regulates DNA damage response.
Br J Cancer. 2024;131:534-550. PubMedAbstract available
July 2024
ANGERILLI V, Sabella G, Simbolo M, Lagano V, et al Comprehensive genomic and transcriptomic characterization of high-grade
gastro-entero-pancreatic neoplasms.
Br J Cancer. 2024;131:159-170. PubMedAbstract available
VALOUS NA, Popp F, Zornig I, Jager D, et al Graph machine learning for integrated multi-omics analysis.
Br J Cancer. 2024;131:205-211. PubMedAbstract available
June 2024
TSOULAKI O, Tischkowitz M, Antoniou AC, Musgrave H, et al Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical
practice.
Br J Cancer. 2024;130:2027-2036. PubMedAbstract available
May 2024
MENG XN, Ma JF, Liu YH, Li SQ, et al Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond
DHFR amplification suggest potential new targets for preventing drug resistance.
Br J Cancer. 2024;130:1819-1827. PubMedAbstract available
April 2024
DHAR C, Ramachandran P, Xu G, Pickering C, et al Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic
profiling.
Br J Cancer. 2024 Apr 24. doi: 10.1038/s41416-024-02644. PubMedAbstract available
March 2024
FELIU J, Gamez-Pozo A, Martinez-Perez D, Perez-Wert P, et al Functional proteomics of colon cancer Consensus Molecular Subtypes.
Br J Cancer. 2024 Mar 14. doi: 10.1038/s41416-024-02650. PubMedAbstract available
February 2024
PRETE AA, Angerilli V, Bergamo F, Vettore V, et al HER2 expression and genOmic characterization of rESected brain metastases from
colorectal cancer: the HEROES study.
Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-023-02569. PubMedAbstract available
January 2024
WANG Y, He M, He T, Ouyang X, et al Integrated genomic and transcriptomic analysis reveals the activation of PI3K
signaling pathway in HPV-independent cervical cancers.
Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555. PubMedAbstract available
HALLAL SM, Tuzesi A, Sida LA, Xian E, et al Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential
for a 'liquid gold' biopsy.
Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02548. PubMedAbstract available
December 2023
GRASSMANN F, Malarstig A, Dahl L, Bendes A, et al The impact of circulating protein levels identified by affinity proteomics on
short-term, overall breast cancer risk.
Br J Cancer. 2023 Dec 22. doi: 10.1038/s41416-023-02541. PubMedAbstract available
September 2023
PAYNE K, Brooks J, Batis N, Khan N, et al Feasibility of mass cytometry proteomic characterisation of circulating tumour
cells in head and neck squamous cell carcinoma for deep phenotyping.
Br J Cancer. 2023 Sep 21. doi: 10.1038/s41416-023-02428. PubMedAbstract available
YANG Y, Xu S, Jia G, Yuan F, et al Integrating genomics and proteomics data to identify candidate plasma biomarkers
for lung cancer risk among European descendants.
Br J Cancer. 2023 Sep 7. doi: 10.1038/s41416-023-02419. PubMedAbstract available
LIU Z, Duan T, Zhang Y, Weng S, et al Radiogenomics: a key component of precision cancer medicine.
Br J Cancer. 2023;129:741-753. PubMedAbstract available
August 2023
VAN MOURIK A, Tonkin-Hill G, O'Farrell J, Waller S, et al Six-year experience of Australia's first dedicated cancer of unknown primary
clinic.
Br J Cancer. 2023;129:301-308. PubMedAbstract available
July 2023
LEE JE, Kim KT, Shin SJ, Cheong JH, et al Genomic and evolutionary characteristics of metastatic gastric cancer by routes.
Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02338. PubMedAbstract available
June 2023
XU L, Su H, Zhao S, Si H, et al Development of the semi-dry dot-blot method for intraoperative detecting
micropapillary component in lung adenocarcinoma based on proteomics analysis.
Br J Cancer. 2023;128:2116-2125. PubMedAbstract available
KITAGAWA A, Osawa T, Noda M, Kobayashi Y, et al Convergent genomic diversity and novel BCAA metabolism in intrahepatic
cholangiocarcinoma.
Br J Cancer. 2023;128:2206-2217. PubMedAbstract available
May 2023
RASMUSSEN SV, Wozniak A, Lathara M, Goldenberg JM, et al Functional genomics of human clear cell sarcoma: genomic, transcriptomic and
chemical biology landscape for clear cell sarcoma.
Br J Cancer. 2023;128:1941-1954. PubMedAbstract available
April 2023
ROSSWOG C, Fassunke J, Ernst A, Schomig-Markiefka B, et al Genomic ALK alterations in primary and relapsed neuroblastoma.
Br J Cancer. 2023;128:1559-1571. PubMedAbstract available
March 2023
CIFUENTES GA, Santiago A, Mendez Blanco L, Fueyo M, et al Clinical utility of liquid biopsy and integrative genomic profiling in
early-stage and oligometastatic cancer patients treated with radiotherapy.
Br J Cancer. 2023;128:857-876. PubMedAbstract available
February 2023
NJOKU K, Pierce A, Geary B, Campbell AE, et al Quantitative SWATH-based proteomic profiling of urine for the identification of
endometrial cancer biomarkers in symptomatic women.
Br J Cancer. 2023 Feb 17. doi: 10.1038/s41416-022-02139. PubMedAbstract available
CHEN G, Zhang J, Fu Q, Taly V, et al Integrative analysis of multi-omics data for liquid biopsy.
Br J Cancer. 2023;128:505-518. PubMedAbstract available